Literature DB >> 31010831

Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy.

Karine Nguyen1,2, Natacha Broucqsault2, Charlene Chaix1, Stephane Roche2, Jérôme D Robin2, Catherine Vovan1, Laurene Gerard1, André Mégarbané3, Jon Andoni Urtizberea4, Remi Bellance5, Christine Barnérias6,7, Albert David8, Bruno Eymard9, Melanie Fradin10, Véronique Manel11, Sabrina Sacconi12,13, Vincent Tiffreau14, Fabien Zagnoli15, Jean-Marie Cuisset16, Emmanuelle Salort-Campana2,17, Shahram Attarian2,17, Rafaëlle Bernard1,2, Nicolas Lévy1,2, Frederique Magdinier18.   

Abstract

BACKGROUND: Subtelomeres are variable regions between telomeres and chromosomal-specific regions. One of the most studied pathologies linked to subtelomeric imbalance is facioscapulohumeral dystrophy (FSHD). In most cases, this disease involves shortening of an array of D4Z4 macrosatellite elements at the 4q35 locus. The disease also segregates with a specific A-type haplotype containing a degenerated polyadenylation signal distal to the last repeat followed by a repetitive array of β-satellite elements. This classification applies to most patients with FSHD. A subset of patients called FSHD2 escapes this definition and carries a mutation in the SMCHD1 gene. We also recently described patients carrying a complex rearrangement consisting of a cis-duplication of the distal 4q35 locus identified by molecular combing.
METHODS: Using this high-resolution technology, we further investigated the organisation of the 4q35 region linked to the disease and the 10q26 locus presenting with 98% of homology in controls and patients.
RESULTS: Our analyses reveal a broad variability in size of the different elements composing these loci highlighting the complexity of these subtelomeres and the difficulty for genomic assembly. Out of the 1029 DNA samples analysed in our centre in the last 7 years, we also identified 54 cases clinically diagnosed with FSHD carrying complex genotypes. This includes mosaic patients, patients with deletions of the proximal 4q region and 23 cases with an atypical chromosome 10 pattern, infrequently found in the control population and never reported before.
CONCLUSION: Overall, this work underlines the complexity of these loci challenging the diagnosis and genetic counselling for this disease. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  facio scapulo humeral dystrophy; molecular combing; smchd1; subtelomeres

Mesh:

Year:  2019        PMID: 31010831     DOI: 10.1136/jmedgenet-2018-105949

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  High-resolution breakpoint junction mapping of proximally extended D4Z4 deletions in FSHD1 reveals evidence for a founder effect.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; David San Leon Granado; Nienke van der Stoep; Henk Buermans; Robin van Schendel; Joost Schimmel; Marianne de Visser; Rudy van Coster; Marc Jeanpierre; Pascal Laforet; Meena Upadhyaya; Baziel van Engelen; Sabrina Sacconi; Rabi Tawil; Nicol C Voermans; Mark Rogers; Silvère M van der Maarel
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 5.121

2.  Chromosome 10q-linked FSHD identifies DUX4 as principal disease gene.

Authors:  Richard J L F Lemmers; Patrick J van der Vliet; Ana Blatnik; Judit Balog; Janez Zidar; Don Henderson; Rianne Goselink; Stephen J Tapscott; Nicol C Voermans; Rabi Tawil; George W A M Padberg; Baziel Gm van Engelen; Silvère M van der Maarel
Journal:  J Med Genet       Date:  2021-01-12       Impact factor: 6.318

3.  CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.

Authors:  Autumn Rieken; Aaron D Bossler; Katherine D Mathews; Steven A Moore
Journal:  Neurology       Date:  2020-12-21       Impact factor: 9.910

4.  Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.

Authors:  Lucia Ruggiero; Fabiano Mele; Fiore Manganelli; Dario Bruzzese; Giulia Ricci; Liliana Vercelli; Monica Govi; Antonio Vallarola; Silvia Tripodi; Luisa Villa; Antonio Di Muzio; Marina Scarlato; Elisabetta Bucci; Giovanni Antonini; Lorenzo Maggi; Carmelo Rodolico; Giuliano Tomelleri; Massimiliano Filosto; Stefano Previtali; Corrado Angelini; Angela Berardinelli; Elena Pegoraro; Maurizio Moggio; Tiziana Mongini; Gabriele Siciliano; Lucio Santoro; Rossella Tupler
Journal:  JAMA Netw Open       Date:  2020-05-01

5.  Methylation hotspots evidenced by deep sequencing in patients with facioscapulohumeral dystrophy and mosaicism.

Authors:  Stéphane Roche; Camille Dion; Natacha Broucqsault; Camille Laberthonnière; Marie-Cécile Gaillard; Jérôme D Robin; Arnaud Lagarde; Francesca Puppo; Catherine Vovan; Charlene Chaix; Emmanuelle Salort Campana; Shahram Attarian; Marc Bartoli; Rafaelle Bernard; Karine Nguyen; Frédérique Magdinier
Journal:  Neurol Genet       Date:  2019-11-14

Review 6.  Does DNA Methylation Matter in FSHD?

Authors:  Valentina Salsi; Frédérique Magdinier; Rossella Tupler
Journal:  Genes (Basel)       Date:  2020-02-28       Impact factor: 4.096

Review 7.  Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update.

Authors:  Teresa Schätzl; Lars Kaiser; Hans-Peter Deigner
Journal:  Orphanet J Rare Dis       Date:  2021-03-12       Impact factor: 4.123

Review 8.  Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD.

Authors:  Valerio Caputo; Domenica Megalizzi; Carlo Fabrizio; Andrea Termine; Luca Colantoni; Carlo Caltagirone; Emiliano Giardina; Raffaella Cascella; Claudia Strafella
Journal:  Cells       Date:  2022-08-29       Impact factor: 7.666

Review 9.  DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation.

Authors:  Eva Sidlauskaite; Laura Le Gall; Virginie Mariot; Julie Dumonceaux
Journal:  J Pers Med       Date:  2020-07-28

10.  A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.

Authors:  Andre Megarbane; Sami Bizzari; Asha Deepthi; Sandra Sabbagh; Hicham Mansour; Eliane Chouery; Ghassan Hmaimess; Rosette Jabbour; Cybel Mehawej; Saada Alame; Abeer Hani; Dana Hasbini; Ismat Ghanem; Salam Koussa; Mahmoud Taleb Al-Ali; Marc Obeid; Diana Bou Talea; Gerard Lefranc; Nicolas Lévy; France Leturcq; Stephany El Hayek; Valérie Delague; J Andoni Urtizberea
Journal:  J Neuromuscul Dis       Date:  2022
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.